Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

13.83
+1.209.50%
Post-market: 13.81-0.0217-0.16%19:39 EDT
Volume:3.68M
Turnover:50.61M
Market Cap:1.09B
PE:6.53
High:14.19
Open:13.09
Low:13.01
Close:12.63
52wk High:17.29
52wk Low:5.70
Shares:78.65M
Float Shares:72.22M
Volume Ratio:2.42
T/O Rate:5.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.12
EPS(LYR):1.87
ROE:82.56%
ROA:2.29%
PB:4.69
PE(LYR):7.40

Loading ...

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

GlobeNewswire
·
Jun 29

Hengrui Wins Landmark NMPA Nod for New Lung Cancer Use of PD-L1 Drug

TIPRANKS
·
Jun 25

Analysts Offer Insights on Technology Companies: PagerDuty (PD), Zebra Tech (ZBRA) and Oracle (ORCL)

TIPRANKS
·
Jun 23

Analysts Have Conflicting Sentiments on These Technology Companies: PagerDuty (PD) and International Business Machines (IBM)

TIPRANKS
·
Jun 23

PagerDuty Names Eric Prengel as CFO

MT Newswires Live
·
Jun 23

PagerDuty names Eric Prengel as new CFO

TIPRANKS
·
Jun 23

PagerDuty shareholders elected four directors at annual meeting

Reuters
·
Jun 23

PagerDuty names Eric Prengel CFO as Howard Wilson retires

Reuters
·
Jun 23

PagerDuty Appoints Eric Prengel as Chief Financial Officer

THOMSON REUTERS
·
Jun 23

How Investors Are Reacting To Agilent Technologies (A) Expanding PD-L1 Test Use And Launching New AI Partnership

Simply Wall St.
·
Jun 16

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

GlobeNewswire
·
Jun 15

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

GlobeNewswire
·
Jun 14

SIMCERE PHARMA Receives NMPA Approval for Clinical Trial of SIM0689, a Dual-Target Antibody

Stock News
·
Jun 12

Simcere Wins NMPA Green Light for PD-1/VEGF Bispecific Cancer Therapy

TIPRANKS
·
Jun 12

PagerDuty survey finds 66% of office professionals use unauthorized AI tools at work

Reuters
·
Jun 11

Press Release: AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson's Disease

Dow Jones
·
Jun 11

Southwest Securities: Post-PD-(L)1 Treatment Resistance Poses Significant Challenge, 2026 to See High Concentration of Catalysts

Stock News
·
Jun 11

PagerDuty announces Ingram Micro as authorized distributor in Australia

TIPRANKS
·
Jun 09

PagerDuty names Ingram Micro exclusive distributor in Australia

Reuters
·
Jun 09

PagerDuty Expands Australia Footprint With Exclusive Distribution Agreement With Ingram Micro

THOMSON REUTERS
·
Jun 09